ImmGenics Pharmaceuticals Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $75.4M

  • Investors
  • 1

ImmGenics Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company intended to develop a proprietary technology for antibody drug discovery. The company's lymphocyte antibody technology cultures the B-cells directly and assays them over a period of days using a microplate-based throughput system and increases the number of antibodies that can be screened for any given antigen target.

Contact Information

Website
www.immgenics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6660 North West Marine Drive
  • 3rd Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Abgenix
Vertical(s)
Life Sciences
Corporate Office
  • 6660 North West Marine Drive
  • 3rd Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmGenics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 06-Nov-2000 $75.4M Completed Generating Revenue
4. Later Stage VC 16-May-2000 Completed Generating Revenue
3. Later Stage VC 01-Nov-1999 Completed Generating Revenue
2. Corporate 01-Nov-1998 $2.91M $2.91M Completed Generating Revenue
1. University Spin-Out 01-Jan-1993 Completed Startup
To view ImmGenics Pharmaceuticals’s complete valuation and funding history, request access »

ImmGenics Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corixa Corporation Minority
International Biotechnology Trust Venture Capital Minority
Phase4 Partners Venture Capital Minority
To view ImmGenics Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

ImmGenics Pharmaceuticals FAQs

  • When was ImmGenics Pharmaceuticals founded?

    ImmGenics Pharmaceuticals was founded in 1993.

  • Where is ImmGenics Pharmaceuticals headquartered?

    ImmGenics Pharmaceuticals is headquartered in Vancouver, Canada.

  • What industry is ImmGenics Pharmaceuticals in?

    ImmGenics Pharmaceuticals’s primary industry is Drug Discovery.

  • Is ImmGenics Pharmaceuticals a private or public company?

    ImmGenics Pharmaceuticals is a Private company.

  • What is the current valuation of ImmGenics Pharmaceuticals?

    The current valuation of ImmGenics Pharmaceuticals is .

  • What is ImmGenics Pharmaceuticals’s current revenue?

    The current revenue for ImmGenics Pharmaceuticals is .

  • How much funding has ImmGenics Pharmaceuticals raised over time?

    ImmGenics Pharmaceuticals has raised $9.9M.

  • Who are ImmGenics Pharmaceuticals’s investors?

    Corixa, International Biotechnology Trust, and Phase4 Partners have invested in ImmGenics Pharmaceuticals.

  • When was ImmGenics Pharmaceuticals acquired?

    ImmGenics Pharmaceuticals was acquired on 06-Nov-2000.

  • Who acquired ImmGenics Pharmaceuticals?

    ImmGenics Pharmaceuticals was acquired by Abgenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process